Diphenoxylate (μ-opioid agonist with limited CNS access at therapeutic doses) + atropine (anticholinergic — added to deter abuse). Used for symptomatic diarrhea. Schedule V due to abuse-potential precedent; loperamide largely supplanted it.
Half-Life & Elimination Curve (PO: 7.24h)
Plasma (PO)t½ Decay (7.24h)
0×t½0h100%(42.6 µg/L)
1×t½7.24h50%(21.3 µg/L)
2×t½14.5h25%(10.7 µg/L)
3×t½21.7h12.5%(5.33 µg/L)
4×t½29h6.3%(2.66 µg/L)
5×t½36.2h3.1%(1.33 µg/L)
Elimination t½7.24h (PO)
Rate Constant (ke)0.0957 h⁻¹
Time to Peak (Tmax)2.9h
Est. Peak (Cmax)42.6 µg/L
Clearance (CL)7.66 L/h
97% Washout (5×t½)36.2h
Dosing Guidelines
Oral (PO): Typical 5 mg (Range: 2.5–20 mg)
Pharmacokinetic Parameters
Oral (PO): Bioavailability (F): 90% · Volume of Distribution (Vd): 80 L · Absorption (ka): 0.85 h⁻¹ (t½ka ≈ 49m) [PMID 3682841]